Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The Journal of School Nursing : the Official Publication of the National Association of School Nurses|April 1, 1996
The evolution of the school nurse practitioner: past, present, and futureD Urbinati, P Steele, B J Harter, et al.
Annales Pharmaceutiques Francaises|October 1, 2013
[Innovative medicines and market access agreements]M Toumi, J Zard, R Duvillard, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
A pharmacoeconomic evaluation of zuclopenthixol compared with haloperidol and risperidone in the treatment of schizophreniaK Hansen, C François, M Toumi, et al.
Journal of Medical Economics|April 20, 2013
Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future developmentJ Cohen, A Millier, S Karray, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 2, 2010
Increasing escitalopram dose is associated with fewer discontinuations than switch or combination approaches in patients initially on escitalopram 10 mgT Sanglier, D Milea, D Saragoussi, et al.
Pharmacopsychiatry|June 14, 2003
Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatmentW Löffler, R Kilian, M Toumi, et al.
Acta Psychiatrica Scandinavica|July 6, 2004
Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychoticsR Kilian, S Dietrich, M Toumi, et al.
L'Encephale|June 12, 1998
[Cost of illness: an inextricable maze or an aid in decision making? The case of schizophrenia]R Launois, M Toumi, J Reboul-Marty, et al.
Pageof 5